Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunofluorescence in dermatology.

D F Mutasim1, B B Adams

  • 1Department of Dermatology, University of Cincinnati, Ohio 45267-0592, USA. mutasidf@email.uc.edu

Journal of the American Academy of Dermatology
|November 17, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Successful treatment of disseminated granuloma annulare with methotrexate.

The British journal of dermatology·2010
Same author

Lupus erythematosus tumidus as a separate subtype of cutaneous lupus erythematosus.

The British journal of dermatology·2010
Same author

Red plaque on a high school wrestler.

The Physician and sportsmedicine·2010
Same author

Running-related toenail abnormality.

The Physician and sportsmedicine·2010
Same author

Melanocytic nevi of the auricular region: histologic characteristics and diagnostic difficulties.

The American Journal of dermatopathology·2005
Same author

The wear and tear of 26.2: dermatological injuries reported on marathon day.

British journal of sports medicine·2004

Accurate diagnosis of immune-mediated skin diseases relies on combining clinical, histologic, and immunofluorescence findings. Immunofluorescence testing is crucial for confirming suspected diagnoses, especially in subepidermal bullous diseases with overlapping features.

Area of Science:

  • Dermatology
  • Immunology
  • Pathology

Background:

  • Accurate diagnosis of bullous and immune-mediated skin diseases requires integrating clinical, histologic, and immunofluorescence data.
  • Immunofluorescence (IF) is a key diagnostic tool in dermatology.
  • Subepidermal bullous diseases often present with overlapping clinical and histologic features, necessitating advanced diagnostic methods.

Purpose of the Study:

  • To highlight the indispensable role of immunofluorescence testing in diagnosing skin diseases.
  • To emphasize the importance of combining multiple diagnostic modalities for accurate disease identification.

Main Methods:

  • Direct immunofluorescence (DIF) is the primary method discussed.
  • DIF is performed on perilesional skin for bullous diseases.

Related Experiment Videos

  • DIF is performed on lesional skin for connective tissue diseases and vasculitis.

    • Main Results:

    • Immunofluorescence testing is invaluable for confirming diagnoses suspected from clinical or histologic examination.
    • This technique is particularly critical for differentiating subepidermal bullous diseases with similar presentations.
    • The method allows for precise localization of immune deposits.

    Conclusions:

    • Accurate diagnosis of bullous and immune skin diseases is achieved through a comprehensive approach.
    • Immunofluorescence testing is essential for confirming diagnoses, especially in challenging cases like subepidermal bullous diseases.
    • The appropriate sample site (perilesional vs. lesional skin) is critical for diagnostic yield.